Erfan G, Puig S, Carrera C, Arance A, Gaba L, Victoria I, et al. Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors. Acta Derm Venereol [Internet]. 2016 Sep. 12 [cited 2026 Jul. 21];97(2):258-60. Available from: https://medicaljournalssweden.se/actadv/article/view/4950